Strategies to Improve Antineoplastic Activity of Drugs in Cancer Progression

© 2022 by the authors; CC BY-NC-ND license

EGR-1; flavonoid; (E)-5-((4-oxo-4H-chromen-3-yl)methyleneamino)-1-phenyl-1H-pyrazole-4-carbonitrile; MDA-MB-231; MMP9; TNFα; pancreatic ductal adenocarcinoma; cyclodextrin inclusion complex; phase solubility studies; preformulation studies; biphenylnicotinamide derivatives; dual inhibitor; EGFR; VEGFR2; ligand-based pharmacophore; molecular docking; molecular dynamics; leukemias; doxorubicin; inflammation; drug delivery; tumor targeting; elastin-like polypeptide; cell penetrating peptide; matrix metalloproteinase; doxorubicin resistance; photosensitizer delivery system; PAMAM dendrimer; photodynamic therapy; cytotoxicity; phototoxicity; colorectal adenocarcinoma; dicarboximides; chemical synthesis; cytotoxicity; apoptosis; kinases; anticancer; gene profiling; SAR; biomarkers; colorectal cancer; early detection examination; liquid biopsy; personalized medicine; tumor treatment; exosomes; ctDNA; CTC; cytotoxic activity; pyrazole derivatives; MTT assay; ADMET analysis; single-crystal diffraction; FTIR spectroscopy; NMR spectroscopy thermogravimetric analysis; acute myelogenous leukemia; platelets; microparticles; apoptosis; γδ T cells; immunotherapy; tumor resistance; combination therapy; tumor microenvironment; immune checkpoint inhibitor; neuroblastoma; molecular iodine; cyclophosphamide; xenografts; metronomic therapy; tamoxifen; CYP2D6; MCF-7; Ishikawa cells; SERM; TNBC; uterotrophic; α-mangostin; poly(amidoamine) dendrimer; targeted drug delivery; biotin targeting; glioblastoma multiforme; squamous cell carcinoma; antiparasitic therapy; diclofenac; indomethacin; oleanolic acid derivative conjugates; NF-κB; Nrf2; MAPKs; PSN-1 cells; inflammation; reactive oxygen species; glioblastoma; brain tumor; drug delivery; extracellular vesicles; pancreatic cancer; paclitaxel; clathrin; endocytosis; sulforaphane; nicotine; metalloproteinase-9; gastric cancer; cell invasion; Arylquin 1; colon cancer; tumor progression; apoptosis; azelastine; oxidative stress; autophagy; apoptosis; mitotic catastrophe; chronic myeloid leukemia; imatinib; tyrosine kinase; ketoconazole; P-glycoprotein; drug efflux transporter; non-small-cell lung cancer; cisplatin resistance; aldehyde dehydrogenase; isothiocyanates; disulfiram; epithelial to mesenchymal transition; aminopeptidase N; acetamidophenones; Schiff bases; semicarbazones; thiosemicarbazones; inhibition of proliferation